International Journal of Colorectal Disease

, Volume 25, Issue 6, pp 695–702

The impact of expressions of CD97 and its ligand CD55 at the invasion front on prognosis of rectal adenocarcinoma

  • Shao-Liang Han
  • Chang Xu
  • Xiu-Ling Wu
  • Jun-Lin Li
  • Zhi Liu
  • Qi-Qiang Zeng
Original Article

DOI: 10.1007/s00384-010-0926-5

Cite this article as:
Han, SL., Xu, C., Wu, XL. et al. Int J Colorectal Dis (2010) 25: 695. doi:10.1007/s00384-010-0926-5
  • 150 Downloads

Abstract

Background

Various evidence show that CD97 plays an important role in tumor differentiation, migration, invasiveness, and metastasis by binding its cellular ligand CD55. CD55 is a complement regulatory protein expressed by cells to protect them from bystander attack by complement, and it has been shown to be an indicator of poor prognostic in several cancers.

Methods

CD97 and CD55 stains were detected in tumor tissues from 71 cases of rectal adenocarcinomas and their corresponding normal colorectal tissues by immunohistochemistry.

Results

The expressions of CD97 and CD55 in rectal tumor tissues were significantly higher than those in normal colorectal tissues (P < 0.05, both). The patients with recurrence and/or metastasis had significantly higher expressions of CD97 at tumor cells and CD55 at stroma (67.8% [21/31] and 63.6% [21/33]) at the invasion front than those patients without recurrence and/or metastasis (25.0% [10/40] and 26.3% [10/38]). The expression of CD97 at tumor cell at the invasion front showed modest correlation with that of CD55 in the stroma at the invasion front(r = 0.392, P < 0.01). Univariate analysis revealed that lymph node metastasis (P = 0.001), stages II–IV (P = 0.026), and strong CD97 expression at tumor invasion front (P = 0.002) were shown to have a significant adverse impact on the postoperative survival rate. Moreover, lymph node metastasis (P = 0.037) and strong CD97 expression (P = 0.015) were associated with poor survival in a multivariate analysis.

Conclusions

Elevated expression of CD97 and its ligand CD55 at the invasion front correlate with tumor recurrence and metastasis, and CD95 may be a poor prognostic factor for rectal adenocarcinoma.

Keywords

CD97 CD55 Prognosis Rectal adenocarcinoma Metastasis 

Copyright information

© Springer-Verlag 2010

Authors and Affiliations

  • Shao-Liang Han
    • 1
  • Chang Xu
    • 1
  • Xiu-Ling Wu
    • 2
  • Jun-Lin Li
    • 1
  • Zhi Liu
    • 1
  • Qi-Qiang Zeng
    • 1
  1. 1.Department of General Surgerythe First Affiliated Hospital of Wenzhou Medical CollegeWenzhouChina
  2. 2.Department of Histopathologythe First Affiliated Hospital of Wenzhou Medical CollegeWenzhouChina

Personalised recommendations